Martin Kolb
Martin Kolb
Professor of Medicine, McMaster University Hamilton
Verified email at
Cited by
Cited by
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
Nintedanib in progressive fibrosing interstitial lung diseases
KR Flaherty, AU Wells, V Cottin, A Devaraj, SLF Walsh, Y Inoue, ...
New England Journal of Medicine 381 (18), 1718-1727, 2019
Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report
HR Collard, CJ Ryerson, TJ Corte, G Jenkins, Y Kondoh, DJ Lederer, ...
American journal of respiratory and critical care medicine 194 (3), 265-275, 2016
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
A Moeller, K Ask, D Warburton, J Gauldie, M Kolb
The international journal of biochemistry & cell biology 40 (3), 362-382, 2008
Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis
M Kolb, PJ Margetts, DC Anthony, F Pitossi, J Gauldie
The Journal of clinical investigation 107 (12), 1529-1536, 2001
Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis
L Wollin, E Wex, A Pautsch, G Schnapp, KE Hostettler, S Stowasser, ...
European Respiratory Journal 45 (5), 1434-1445, 2015
Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis
A Moeller, SE Gilpin, K Ask, G Cox, D Cook, J Gauldie, PJ Margetts, ...
American journal of respiratory and critical care medicine 179 (7), 588-594, 2009
Smad3 null mice develop airspace enlargement and are resistant to TGF-β-mediated pulmonary fibrosis
P Bonniaud, M Kolb, T Galt, J Robertson, C Robbins, M Stampfli, C Lavery, ...
The Journal of Immunology 173 (3), 2099-2108, 2004
Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals
DJ Lederer, SC Bell, RD Branson, JD Chalmers, R Marshall, DM Maslove, ...
Annals of the American Thoracic Society 16 (1), 22-28, 2019
Proteoglycans decorin and biglycan differentially modulate TGF-β-mediated fibrotic responses in the lung
M Kolb, PJ Margetts, PJ Sime, J Gauldie
American Journal of Physiology-Lung Cellular and Molecular Physiology 280 (6 …, 2001
Progressive transforming growth factor β1–induced lung fibrosis is blocked by an orally active ALK5 kinase inhibitor
P Bonniaud, PJ Margetts, M Kolb, JA Schroeder, AM Kapoun, D Damm, ...
American journal of respiratory and critical care medicine 171 (8), 889-898, 2005
TGF-β and Smad3 signaling link inflammation to chronic fibrogenesis
P Bonniaud, PJ Margetts, K Ask, K Flanders, J Gauldie, M Kolb
The Journal of Immunology 175 (8), 5390-5395, 2005
Gene transfer of transforming growth factor-β1 to the rat peritoneum: effects on membrane function
PJ Margetts, M Kolb, T Galt, CM Hoff, TR Shockley, J Gauldie
Journal of the American Society of Nephrology 12 (10), 2029-2039, 2001
Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin
M Kolb, PJ Margetts, T Galt, PJ Sime, Z Xing, M Schmidt, J Gauldie
American journal of respiratory and critical care medicine 163 (3), 770-777, 2001
Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised …
AU Wells, KR Flaherty, KK Brown, Y Inoue, A Devaraj, L Richeldi, T Moua, ...
The lancet Respiratory medicine 8 (5), 453-460, 2020
Impact of comorbidities on mortality in patients with idiopathic pulmonary fibrosis
M Kreuter, S Ehlers-Tenenbaum, K Palmowski, J Bruhwyler, U Oltmanns, ...
PloS one 11 (3), e0151425, 2016
VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats
L Farkas, D Farkas, K Ask, A Möller, J Gauldie, P Margetts, M Inman, ...
The Journal of clinical investigation 119 (5), 1298-1311, 2009
TGF-β, Smad3 and the process of progressive fibrosis
J Gauldie, P Bonniaud, P Sime, K Ask, M Kolb
Biochemical Society Transactions 35 (4), 661-664, 2007
Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors
L Farkas, J Gauldie, NF Voelkel, M Kolb
American journal of respiratory cell and molecular biology 45 (1), 1-15, 2011
Re-evaluation of fibrogenic cytokines in lung fibrosis
M Kelly, M Kolb, P Bonniaud, J Gauldie
Current pharmaceutical design 9 (1), 39-49, 2003
The system can't perform the operation now. Try again later.
Articles 1–20